Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omto.2022.04.008
PubMed Identifier: 35615262
Publication URI: http://europepmc.org/abstract/MED/35615262
Type: Journal Article/Review
Volume: 25
Parent Publication: Molecular therapy oncolytics
ISSN: 2372-7705